Akinori Okano

This inventor holds 7 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignee: Rapt Therapeutics, Inc.. Active years: 2020-2024.

USPTO Granted Patents = 7 (Patent Applications = 3)

% Patents Active = 85.7

EPO Patents = 2 (Patent Applications = 5)

Average Co-Inventor Count = 11.0

ph-index = 2

Forward Citations = 12(Granted Patents)

Company Filing History:

7 out of 13

Rapt Therapeutics, Inc.

patents

Years Active: 2020-2024

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12098139 - Chemokine receptor modulators and uses thereof (2024-09-24),

2. 11384064 - Chemokine receptor modulators and uses thereof (2022-07-12),

3. 11192879 - Chemokine receptor modulators and uses thereof (2021-12-07),

4. 11084829 - Ubiquitin-specific-processing protease 7 (USP7) modulators and uses thereof (2021-08-10),

5. 11046699 - Pyrazolo-pyrimidin-amino-cycloalkyl compounds and their therapeutic uses (2021-06-29),

6. 10722514 - Ubiquitin-specific-processing protease 7 (USP7) modulators and uses thereof (2020-07-28),

7. 10683280 - Chemokine receptor modulators and uses thereof (2020-06-16),

Title: Akinori Okano: Innovator in Chemokine Receptor Modulation

Introduction

Akinori Okano is a prominent inventor based in San Mateo, California. He has made significant contributions to the field of biochemistry, particularly in the area of chemokine receptor modulation. With a total of seven patents to his name, Okano's work has the potential to impact various therapeutic applications.

Latest Patents

Among his latest patents, Okano has developed compounds and methods for the modulation of certain chemokine receptor activity. These innovations are crucial for advancing treatments related to immune response and inflammation. His work in this area demonstrates a commitment to addressing complex biological challenges through innovative solutions.

Career Highlights

Throughout his career, Akinori Okano has worked with notable companies such as Rapt Therapeutics, Inc. and AbbVie Inc. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Okano has collaborated with talented individuals in his field, including Jacob Bradley Schwarz and David Juergen Wustrow. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Akinori Okano's contributions to chemokine receptor modulation highlight his role as a leading inventor in the biochemistry sector. His patents and collaborations reflect a dedication to advancing medical science and improving therapeutic options.

Profile summary based on public USPTO records.